Topics

Companies Related to "A Novel Treatment Intervention for Improving Metabolism" [Most Relevant Company Matches] RSS

06:25 EST 18th January 2020 | BioPortfolio

Here are the most relevant search results for "A Novel Treatment Intervention for Improving Metabolism" found in our extensive corporate database of over 50,000 company records.

Showing "Novel Treatment Intervention Improving Metabolism" Companies 1–25 of 4,700+

Relevant

Neural Intervention Technologies, Inc.

Neural Intervention Technologies (NIT) is a development stage medical device company focused on improving the quality of life of patients with blood vessel defects, including those of the brain that result in hemorrhagic stroke.NIT is developing ALGEL™-I and -II, novel embolic materials, into minimally invasive treatments for cerebral arteriovenous malformations and aneurysms. In addition, NIT w...


SBIRT Colorado

SBIRT or 'Screening, Brief Intervention, Referral to Treatment' is a comprehensive, integrated, public health approach to the delivery of early intervention and referral to treatment services for persons who are at risk of developing substance use disorders, as well as those with substance use disorders. SBIRT Colorado is an initiative of Governor Bill Ritter, Jr.; funded by the Substance Abuse an...

Agios Pharmaceuticals, Inc.

Agios is the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Agios has multiple first-in-class programs in cancer metabolism and inborn errors of metabolism advancing toward the clinic, in addition to an active research and discovery pipeline across ...


sphingotec LLC

Headquartered in Hennigsdorf, Germany, biotechnology company sphingotec GmbH was founded in 2002. sphingotec GmbH aims to develop diagnostic methods for prediction, prevention, intervention strategies and early treatment of diseases in the fields of cancer, cardiovascular diseases and kidney function. Using biomarkers to indicate susceptibility for a speci...

sphingotec GmbH

Headquartered in Hennigsdorf, Germany, biotechnology company sphingotec GmbH was founded in 2002. sphingotec GmbH aims to develop diagnostic methods for prediction, prevention, intervention strategies and early treatment of diseases in the fields of cancer, cardiovascular diseases and kidney function. Using biomarkers to indicate susceptibility for a speci...

Agios Pharmaceuticals , Inc.

Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class investigational m...

Lutonix, Inc.

Restenosis is the re-narrowing of an artery experienced by some patients following angioplasty, atherectomy, or stenting. Restenosis is caused by an overgrowth of tissue inside the artery wall at the original treatment site. Restenosis is typically experienced by some patients within the first 6 months of treatment, which most often results in re-intervention or surgery.

Bio-Intervention Specialists

Bio-IS does not replace the environmental services staff. Instead, Bio-IS works with hospital leadership, infection control committees and environmental services to implement a next-generation bio-intervention process. When new infection situations arise, Bio-IS can quickly attack such situations before they become worse.

Endocare, Inc.

Endocare, Inc.--www.endocare.com-- is an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors...

Viz.ai

Viz.ai is a Direct-to-Intervention healthcare company that uses artificial intelligence and deep learning algorithms to analyze medical data and improve medical workflow. Direct-to-Intervention care leverages AI to communicate information about treatable patients straight to a specialist. We remove much of the friction in today’s stroke workflow by ...

Agios Pharmaceuticals

Agios Pharmaceuticals is the first biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging field of cancer metabolism. To support and drive these efforts, Agios is building a robust platform integrating cancer biology, metabolomics, biochemistry and informatics to enable target and biomarker identification...

Immunodiagnostic Systems Ltd. (IDS Ltd.)

SBA Sciences is a Finnish company developing novel immunoassays for bone metabolism studies and diagnostics.BoneTRAP® kit has been developed for detection of bone metastasis and follow up of osteoporosis treatment.

TIESRx

TIESRx™ developed the Treatment Advantage™ with the goal of improving patient outcomes via: (1) increasing patient persistency by addressing discontinuation threats with behavior-based technology innovation; (2) improving patient compliance by supporting full dose on-time adherence; and (3) capturing real-time patient reported outcome measurements.

Racing Ahead

Racing Ahead is a leading provider of assessment and early intervention services for infants and toddlers at risk for developmental delays. Racing Ahead's staff serves as a knowledgeable resource for expert advice, information, intervention, and support for both parents and physicians. Racing Ahead also provides parent workshops and individualized instruction for infants and toddlers to accelera...

Vivos Therapeutics

Founded in 2016, Vivos Therapeutics combines breakthrough technology for specially designed oral appliances with proprietary clinical protocols for obstructive sleep apnea (OSA) treatment that can restore and enhance the human airway. Because its patented FDA Class I and II medical devices are thought to be the first treatment that addresses the root cause...

XableCath, Inc.

XableCath was founded in 2014 to commercialize catheters for the treatment of vascular disease. XableCath technology is revolutionary and allows effective treatment, improving the lives of patients and transforming the ease of vascular interventions for physicians. For more information visit www.xablecath.com.

Symbiotic Research Services

SR is a contract research organization (CRO) which is licensed to conduct research with radio labeled C-14 materials. SR has been inspected by the US-EPA and the NJ-DEP Division of Radioactive Materials. SR is a full GLP compliant laboratory that has expanded its services over the years to cover a broad range of agrochemical R&D services such as product ch...

Probably Relevant

Rheos Medicines

Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop novel therapeutics for patients with severe autoimmune disorders, inflammatory diseases and cancer. Our approach targets the underlying intracellular metabolism of immune cells and has the potential to unlock a new frontier in drug discovery for immune-...

MEDICAL SPECIALISTS

Primary Care for all Ages - Specialists Consultation by AppointmentSpecializing in: Treatment of the Heart, Lung & Kidneys, Dialysis, Arthritis and Bone Disease, Diseases of the Elderly, High Blood Pressure, Diabetes and Metabolism, Women's Health Care, Comprehensive Physical Exams, Employment Physicals, Pediatrics, Workman's Compensation

Raze Therapeutics

Raze Therapeutics is dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways essential to cancer growth and survival. By selectively targeting one-carbon (1C) metabolism using its proprietary platform, Raze is developing a pipeline of 1C metabolism therapeutics across a range of solid an...

Traxtal Inc.

Traxtal, headquartered in Toronto, Canada, is the world leader and proven pioneer in the innovation, development and manufacture of computer assisted soft tissue navigation technologies. Introduced in 2007, its PercuNav system is the only image-guided diagnostic and interventional system cleared by the U.S. Food and Drug Administration that supports all imaging modalities, and the only such system...

NovaDel Pharma Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers, in comparison to conventional oral dosage forms, the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly re...

The Miami Institute for Age Management & Intervention

Advanced Neuromodulation Systems

Welcome to Advanced Neuromodulation Systems Successful treatment of a chronic pain or neurological condition begins with expanding your knowledge and exploring your options.Welcome to Advanced Neuromodulation Systems where our neurostimulation and drug pump technologies are advancing treatment standards for chronic pain and neurological disorders, broadening treatment choices for patients and phys...

Tethys Bioscience, Inc.

Tethys is a cardiometabolic diagnostics company that creates and commercializes breakthrough biomarker-based blood tests that predict imminent disease risk and enable targeted intervention to preempt the onset of chronic conditions such as type 2 diabetes. Tethys introduced its first product -- PreDx® Diabetes Risk Score -- to the market in 2008, and in...


More From BioPortfolio on "A Novel Treatment Intervention for Improving Metabolism"

Quick Search

Corporate Database Quicklinks